BTB Therapeutics, Inc.

BTB Therapeutics, Inc.

Private
Escondido, CaliforniaHealthcare & Life Scienceshttps://btbtherapeutics.com

Last Round

Early Funding

Nov 1, 2025

Total Funding Raised

$10.95M

Momentum Score

25 /100

Company Overview

BTB Therapeutics, Inc. is a drug discovery company developing a non-opioid analgesic and RNA-modifying compounds to treat rare genetic diseases and to enhance the efficacy of cancer immunotherapy.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Government Contracts

AI Layer

Non-AI

Keywords

non-opioid analgesicsmall molecule drugsopioid alternativepain managementcancer immunotherapyimmuno-oncologyrare genetic diseasesdrug discoveryclinical-stage biotechtranscriptomicsRNA regulatordrug licensingpharma partneringfirst-in-class drugneoantigen inducer

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BTB Therapeutics, Inc. Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

BTB Therapeutics, Inc. Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Early FundingNov 1, 2025
SeedFeb 5, 2025
Convertible DebtJun 24, 2024
VC RoundOct 27, 2023
VC RoundApr 6, 2023
Seed
Apr 6, 2021

Key People

Founding team and executive leadership

Masatoshi Hagiwara

Founder Chief Scientific Officer

Founding Team

Takashi Kiyoizumi

Chief Executive Officer

Executive Team

BTB Therapeutics, Inc. Investors

Notable investors and investment history

InvestorRounds
Kyoto University Innovation CapitalEarly Funding, Seed, VC Round
SMBC Venture CapitalEarly Funding, Convertible Debt

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 1, 2025

    $7M raised in early funding.

BTB Therapeutics, Inc. Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

BTB Therapeutics, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about BTB Therapeutics, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersEscondido, California
Employee Range7
Year Founded2020
Last FundingNov 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.